FGC Plasma Solutions partners with UVA's Hypersonic Project to provide an essential piece of highly specialized equipment - plasma...
Read moreThe U.S. Senate unanimously passed the FDA Modernization Act 2.0, S.5002 on September 28. As we shared last month,...
Read moreLinnaeus Therapeutics, Inc. announced that on June 28, 2022 the U.S. Patent and Trademark Office (USPTO) issued U.S. patent 11,369,618 ('618...
Read moreAxial Therapeutics announced that A. Stewart Campbell, Ph.D., will participate in a panel entitled “The Next Wave of Targeted...
Read moreLinnaeus Therapeutics announced the presentation of clinical biomarker data from its study of LNS8801 as a monotherapy and in...
Read moreDr. Jane Goodall and Vivodyne announced that they have delivered a letter to Congress urging its inclusion of the...
Read moreFlash Memory Summit (FMS) is pleased to announce its 2022 Best of Show Award winners. This year's awards recognize...
Read moreSeed Health and Axial Therapeutics announced a joint development program targeting the microbiome-gut-brain axis for mental health, with the potential...
Read moreBehavioral Signals, a Los Angeles-based software company and provider in Conversational AI technology, announces its partnership with ddCom Systems,...
Read moreMemVerge Memory Machine™ has achieved Red Hat OpenShift Operator and container certifications. This is an important step in enabling...
Read more